Corbus Pharmaceuticals Holdings, Inc. (CRBP) Operating income 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual operating income history from SEC filings — each fiscal year as reported.
-$85.3MFY2025 · since FY2016: -$20.0M → -$85.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.3M | -75.1% |
| FY2024 | -$48.7M | -8.1% |
| FY2023 | -$45.1M | -13.2% |
| FY2022 | -$39.8M | +28.9% |
| FY2021 | -$56.0M | +54.4% |
| FY2020 | -$122.8M | -59.3% |
| FY2019 | -$77.1M | -35.9% |
| FY2018 | -$56.7M | -74.3% |
| FY2017 | -$32.6M | -62.9% |
| FY2016 | -$20.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice